Aurobindo Pharma informs about analyst meet

04 Mar 2022 Evaluate
Aurobindo Pharma has informed that S. Subramanian, Chief Financial Officer of the Company, will be participating in virtual event of Goldman Sachs India Pharma and Healthcare Tour 2022 on March 7, 2022. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. 

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1121.65 -18.65 (-1.64%)
21-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.55
Dr. Reddys Lab 1155.50
Cipla 1369.55
Zydus Lifesciences 876.10
Lupin 2139.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×